Effectiveness of Leukocyte Reduction Filters in Treatment of Adult Acute (3)
The threshold between the first and second strategies in regard to risk of refractoriness to leukocyte reduction filters filtered blood components and pooled platelets was 0.30 and 0.27, respectively, without bone marrow transplant and 0.28 and 0.40 with bone marrow transplant. According to a Monte Carlo sensitivity analysis of 500 samples, the second strategy is more cost-effective than the first in 76 percent of cases. It is concluded that the use of filtered blood components is unlikely to increase the cost of treatment.
